PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Heterostructures developed at Purdue support predictions of counterpropagating charged edge modes at the v=2/3 fractional quantum Hall state

2023-02-23
(Press-News.org) In 2018, a team of physicists at Purdue University invented a device which experimentally showed quasiparticles interfering for the first time in the fractional quantum Hall effect at filling factor v=1/3.  Further development of these heterostructures has allowed the Manfra Group to expand their research to experiments that explore counterflowing charged edge modes at the 2/3 fractional quantum Hall state.

They have recently published their findings, “Half-Integer Conductance Plateau at the ν = 2/3 Fractional Quantum Hall State in a Quantum Point Contact,” in Physical Review Letters on February 17, 2023.  This novel work has been selected as the Editor’s Suggestion for the forthcoming issue.  Editor’s Suggestion articles are judged to be particularly important, interesting, and well written.

The team is led by Dr. Michael J. Manfra, Bill and Dee O’Brien Distinguished Professor of Physics and Astronomy, Professor of Electrical and Computer Engineering, Professor of Materials Engineering, and Scientific Director of the Microsoft Quantum Lab West Lafayette.  The lead author of the publication is Dr. James Nakamura, senior research scientist. Dr. Geoffrey Gardner and graduate student Shuang Liang were also co-authors of this publication making valuable contributions to heterostructure growth.

In the experiment, the team produced a semiconductor material which contains a sheet of two-dimensional electrons. On top of this semiconductor, they built a quantum point contact which consists of metal gates with a very narrow 300 nanometer gap. They used the quantum point contact to direct the conducting edge states through the narrow gap.  In this configuration, demonstrated by the graphic above, they were able to measure an electrical conductance equal to half the fundamental value of e2/h.  This experimental result is consistent with longstanding theoretical predictions for the edge states of the ν = 2/3 fractional quantum Hall state.

“We have a semiconductor structure that contains electrons arranged in a plane, called a two-dimensional electron system. When you cool the electrons down to low temperature and put them in a strong magnetic field, they form special states of matter called quantum Hall states,” explains Nakamura.  “At a certain value of the magnetic field, the quantum Hall state is called the ν = 2/3 fractional quantum Hall state. At all quantum Hall states, electrical current is carried by edge states that flow around the edge of the sample, and they are chiral, meaning each edge state only flows in one direction (clockwise or counterclockwise). The ν = 2/3 state is predicted by theoretical physicists to have the special property that the there are two edge states which flow in the opposite direction to each other, one clockwise and the other counterclockwise. This is different from most quantum Hall states, where all the edge states flow in the same direction. We used a device with metal gates called a quantum point contact to control the edge states, and our measurements of the edge states in the quantum point contacts confirm the counterflowing edge states in our device. The quantum point contact brings the edge states on opposite edges of the sample close together. We measured a value of electrical conductance across the device equal to half of the value e2/h, where e is the electron’s charge and h is Planck’s constant. This value of the conductance is strong experimental evidence that our system has the edge structure with two counterflowing edge states.”

This all-Purdue team of physicists is uniquely set up for success at Purdue University due to state-of-the-art facilities spanning semiconductor growth, nanofabrication, and low temperature electrical measurements at the university.

“A crucial aspect is the nanotechnology facilities at Purdue,” says Nakamura. “This includes the machine, called an MBE (molecular beam epitaxy) machine, which is used to produce the semiconductor structures. This very specialized machine, operated by the Manfra group, requires expertise to build and operate so this is an essential advantage at Purdue. Liang, under the guidance of Gardner, is responsible for this aspect of our work. Additionally, the cleanroom in the Birck Nanotechnology Center is a state-of-the-art facility with a wide range of equipment available for us to use, that we used to fabricate the quantum point contact gates. Having all these resources and expertise available at one institution makes our experiments possible.”

This research is part of an ongoing quest to understand and manipulate fractionally charged anyons in fractional quantum Hall regime, a rich testbed for exploring the impact of topology in condensed matter physics which may possibly be used to create qubits.

This research is supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under award number DE-SC0020138.

 

About the Department of Physics and Astronomy at Purdue University

Purdue Department of Physics and Astronomy has a rich and long history dating back to 1904. Our faculty and students are exploring nature at all length scales, from the subatomic to the macroscopic and everything in between. With an excellent and diverse community of faculty, postdocs, and students who are pushing new scientific frontiers, we offer a dynamic learning environment, an inclusive research community, and an engaging network of scholars.  

Physics and Astronomy is one of the seven departments within the Purdue University College of Science. World-class research is performed in astrophysics, atomic and molecular optics, accelerator mass spectrometry, biophysics, condensed matter physics, quantum information science, particle and nuclear physics. Our state-of-the-art facilities are in the Physics Building, but our researchers also engage in interdisciplinary work at Discovery Park District at Purdue, particularly the Birck Nanotechnology Center and the Bindley Bioscience Center.  We also participate in global research including at the Large Hadron Collider at CERN, Argonne National Laboratory, Brookhaven National Laboratory, Fermilab, the Stanford Linear Accelerator, the James Webb Space Telescope, and several observatories around the world. 

 

About Purdue University

Purdue University is a top public research institution developing practical solutions to today’s toughest challenges. Ranked in each of the last five years as one of the 10 Most Innovative universities in the United States by U.S. News & World Report, Purdue delivers world-changing research and out-of-this-world discovery. Committed to hands-on and online, real-world learning, Purdue offers a transformative education to all. Committed to affordability and accessibility, Purdue has frozen tuition and most fees at 2012-13 levels, enabling more students than ever to graduate debt-free. See how Purdue never stops in the persistent pursuit of the next giant leap at https://stories.purdue.edu.

 

 

Written by Cheryl Pierce, Communications Specialist

Contributors: Dr. Michael J. Manfra and Dr. James Nakamura

Graphic by James Nakamura

 

END


ELSE PRESS RELEASES FROM THIS DATE:

Fungi that causes pine ghost canker detected in southern California trees

Fungi that causes pine ghost canker detected in southern California trees
2023-02-23
Fungal pathogens that cause die-back in grape, avocado, citrus, nut and other crops has found a new host and is infecting conifer trees causing Pine Ghost Canker in urban forest areas of Southern California. The canker can be deadly to trees. Scientists from University of California, Davis, first spotted evidence that the pathogens had moved to pines during a routine examination of trees in Orange County in 2018. Over four years, they found that more than 30 mature pines had been infected in an area of nearly 100 acres, according ...

GIST researchers develop “AMP-BERT”: A new AI-based “finder” of antimicrobial peptides

GIST researchers develop “AMP-BERT”: A new AI-based “finder” of antimicrobial peptides
2023-02-23
Over the last few decades, antimicrobial resistance has become a major public health concern globally. This has led to a search for alternative methods of treating microbial infections. One such innovation is the discovery of antimicrobial properties of certain peptides. Antimicrobial peptides (AMPs) are short peptides found in most animals, plants, and microorganisms as a natural defense against infections. AMPs combat harmful bacteria via a nonspecific mechanism that prevents them from developing antimicrobial resistance. Despite these exceptional abilities, research on AMPs is being hindered because the existing systems for identifying candidate ...

Alternate framework for distributed computing tames Big Data’s ever growing costs

Alternate framework for distributed computing tames Big Data’s ever growing costs
2023-02-23
The sheer volume of ‘Big Data’ produced today by various sectors is beginning to overwhelm even the extremely efficient computational techniques developed to sift through all that information. But a new computational framework based on random sampling looks set to finally tame Big Data’s ever-growing communication, memory and energy costs into something more manageable.   A paper describing the framework was published in the journal Big Data Mining and Analytics on Jan. 26.   The amount of data being produced from social networks, business transactions, the ‘Internet of Things’, finance, healthcare and beyond has exploded ...

Insilico Medicine sends first generative AI-designed drug for COVID-19 and variants to clinic

Insilico Medicine sends first generative AI-designed drug for COVID-19 and variants to clinic
2023-02-23
Insilico Medicine, a clinical-stage biotech company powered by generative AI, today announces that China National Medical Products Administration (NMPA) has approved the Investigational New Drug (IND) application for ISM3312, an orally available 3CLpro inhibitor generated and designed with the support of Insilico’s proprietary generative chemistry platform Chemistry42 for the treatment of COVID-19. ISM3312 is a highly selective small molecule inhibitor with a novel molecular structure optimized from compounds which were generated and designed by Chemistry42 based on the structure of 3CL protease. It binds to ...

Children’s lung capacity improved in cleaner air

Children’s lung capacity improved in cleaner air
2023-02-23
As air pollution in Stockholm has decreased, so has the lung capacity of children and adolescents has improved, a new study published in the European Respiratory Journal reports. The researchers from Karolinska Institutet consider the results important, since the lung health of the young greatly affects the risk of their developing chronic lung diseases later in life. “Fortunately, we’ve seen a decrease in air pollutants and therefore an increase in air quality in Stockholm over the past 20 years,” says the study’s last author ...

CityU develops wireless, soft e-skin for interactive touch communication in the virtual world

CityU develops wireless, soft e-skin for interactive touch communication in the virtual world
2023-02-23
Sensing a hug from each other via the internet may be a possibility in the near future. A research team led by City University of Hong Kong (CityU) recently developed a wireless, soft e-skin that can both detect and deliver the sense of touch, and form a touch network allowing one-to-multiuser interaction. It offers great potential for enhancing the immersion of distance touch communication. “With the rapid development of virtual and augmented reality (VR and AR), our visual and auditory senses are not sufficient for us to create an ...

Octapharma USA requests FDA approval for wilate® VWD prophylaxis supplement

Octapharma USA requests FDA approval for wilate® VWD prophylaxis supplement
2023-02-23
PARAMUS, N.J. (Feb. 23, 2023) – Octapharma USA has submitted a Biologics License Application Supplement (sBLA) to the U.S. Food and Drug Administration (FDA) to expand the approval of wilate®, von Willebrand Factor/Coagulation Factor VIII Complex (Human) Lyophilized Powder for Solution for Intravenous Injection, to include routine prophylaxis to reduce the frequency of bleeding episodes in children and adults with any type of von Willebrand disease (VWD). “We look forward to working with the FDA on this sBLA for wilate® ...

Digital markers near-perfect for predicting dementia

2023-02-23
February 23, 2023-- Using ensemble learning techniques and longitudinal data from a large naturalistic driving study, researchers at Columbia University’s Mailman School of Public Health, Fu Foundation School of Engineering and Applied Science, and Vagelos College of Physicians and Surgeons have developed a novel, interpretable and highly accurate algorithm for predicting mild cognitive impairment and dementia in older drivers. Digital markers refer to variables generated from data captured through recording devices in the real-world setting.  These data could be processed to measure driving behavior, performance and tempo-spatial pattern in exceptional detail.  ...

Reducing social media use significantly improves body image in teens, young adults

2023-02-23
Teens and young adults who reduced their social media use by 50% for just a few weeks saw significant improvement in how they felt about both their weight and their overall appearance compared with peers who maintained consistent levels of social media use, according to research published by the American Psychological Association. “Adolescence is a vulnerable period for the development of body image issues, eating disorders and mental illness,” said lead author Gary Goldfield, PhD, of Children's Hospital of Eastern Ontario Research Institute. “Youth ...

Genes reveal kidney cancer’s risk of recurrence 

2023-02-23
A decade-long international study into kidney cancer has shown that doctors can predict the likelihood of a patient’s disease returning by looking at DNA mutations in their tumours.   The research, undertaken by a team of 44 researchers at 23 institutions across Europe and Canada, and published today, is the largest to link the genetic changes that occur in kidney cancer to patient outcomes.  More than 400,000 people are diagnosed with kidney cancer each year globally, including 13,000 ...

LAST 30 PRESS RELEASES:

Azacitidine–venetoclax combination outperforms standard care in acute myeloid leukemia patients eligible for intensive chemotherapy

Adding epcoritamab to standard second-line therapy improves follicular lymphoma outcomes

New findings support a chemo-free approach for treating Ph+ ALL

Non-covalent btki pirtobrutinib shows promise as frontline therapy for CLL/SLL

University of Cincinnati experts present research at annual hematology event

ASH 2025: Antibody therapy eradicates traces of multiple myeloma in preliminary trial

ASH 2025: AI uncovers how DNA architecture failures trigger blood cancer

ASH 2025: New study shows that patients can safely receive stem cell transplants from mismatched, unrelated donors

Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient

Continuous and fixed-duration treatments result in similar outcomes for CLL

Measurable residual disease shows strong potential as an early indicator of survival in patients with acute myeloid leukemia

Chemotherapy and radiation are comparable as pre-transplant conditioning for patients with b-acute lymphoblastic leukemia who have no measurable residual disease

Roughly one-third of families with children being treated for leukemia struggle to pay living expenses

Quality improvement project results in increased screening and treatment for iron deficiency in pregnancy

IV iron improves survival, increases hemoglobin in hospitalized patients with iron-deficiency anemia and an acute infection

Black patients with acute myeloid leukemia are younger at diagnosis and experience poorer survival outcomes than White patients

Emergency departments fall short on delivering timely treatment for sickle cell pain

Study shows no clear evidence of harm from hydroxyurea use during pregnancy

Long-term outlook is positive for most after hematopoietic cell transplant for sickle cell disease

Study offers real-world data on commercial implementation of gene therapies for sickle cell disease and beta thalassemia

Early results suggest exa-cel gene therapy works well in children

NTIDE: Disability employment holds steady after data hiatus

Social lives of viruses affect antiviral resistance

Dose of psilocybin, dash of rabies point to treatment for depression

Helping health care providers navigate social, political, and legal barriers to patient care

Barrow Neurological Institute, University of Calgary study urges “major change” to migraine treatment in Emergency Departments

Using smartphones to improve disaster search and rescue

Robust new photocatalyst paves the way for cleaner hydrogen peroxide production and greener chemical manufacturing

Ultrafast material captures toxic PFAS at record speed and capacity

Plant phenolic acids supercharge old antibiotics against multidrug resistant E. coli

[Press-News.org] Heterostructures developed at Purdue support predictions of counterpropagating charged edge modes at the v=2/3 fractional quantum Hall state